News
1. You may have problems with your prostate that aren’t cancer.
Prostate Cancer companies working in the treatment market are Telix Pharmaceuticals, Merck and Orion, Exelixis, Ipsen Pharma and Takeda, Pfizer, AstraZeneca, Kangpu Biopharmaceuticals, Merus, Blue ...
6d
SurvivorNet on MSN‘A Profound Effect’: Treating Advanced Prostate Cancer With Hormone Therapy
Hormone therapy, also called androgen deprivation therapy (ADT), is the initial treatment for metastatic prostate cancer patients, which occurs when the disease spreads beyond the prostate to areas ...
11d
Tribune Content Agency on MSNHow is metastatic prostate cancer detected and treated in men over 70?
National guidelines on prostate cancer screening with the PSA test are set by the U.S. Preventive Services Task Force (USPSTF ...
Artificial intelligence (AI) is transforming healthcare across multiple fields, and prostate cancer (PCa) is no exception. A recent review conducted by researchers discusses the role of AI in ...
Sandberg said in August 2024 that he was cancer-free after treatment for metastatic prostate cancer. In December, he shared his cancer had returned and spread to other organs.
Ryne Sandberg said his wife, Margaret, was his 'team captain' during his cancer battle In the lengthy post, Sandberg described how his wife had helped him after the cancer diagnosis.
Ryne Sandberg died 19 months after it was announced he was diagnosed with metastatic prostate cancer. Now, doctors are urging early screenings.
Prostate cancer is the second leading cause of death in men right behind heart disease. Patients with this cancer often don’t find out until the disease has advanced quite a bit. But there are ...
Prostate cancer is one of the most common cancers in the world. While many prostate cancers grow slowly and remain localized, other types are aggressive and spread quickly. That's why Dr. Carlos ...
Zoledronic acid reduced fracture risk by 27% in men with metastatic prostate cancer receiving ADT in the STAMPEDE trial. Patients with non-metastatic disease showed no significant fracture benefit ...
ADT is the primary systemic therapy for metastatic hormone-sensitive prostate cancer, used in up to 40% of patients with prostate cancer at some point during treatment for both localised and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results